Skip to search formSkip to main contentSkip to account menu

GS-6624

Known as: GS 6624 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

simtuzumab

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Guidelines for the management of myeloproliferative neoplasms
Polycythemia vera, essential thrombocythemia, and primary myelofibrosis are collectively known as ‘Philadelphia-negative… 
2013
2013
A phase II randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of simtuzumab (GS-6624) combined with gemcitabine as first-line treatment for metastatic pancreatic…
TPS4149 Background: Lysyl oxidase-like molecule 2 (LOXL2) is an extracellular matrix enzyme that catalyzes the covalent cross… 
2012
2012
1000 genomes on Amazon's cloud
volume 30 number 5 maY 2012 nature biotechnology believed to inhibit recruitment, proliferation and activation of fibroblasts… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)